A Lewisburg man who pleaded no contest to attacking his wife with a hammer will see no additional jail time. On Monday, Union County Judge Michael Piecuch sentenced Robert David Kitchens, 67, of ...
Kiromic BioPharma has put 31 people on furlough. The cell therapy biotech has stopped paying the employees, which make up “substantially all” of its workforce, until it raises money to ease its cash ...
March is a crucial month of awareness, research, and fundraising for Multiple Sclerosis (MS). Though a cure remains elusive, ...
NASA's stranded astronauts are finally returning to Earth. But they will face a grueling health battle after spending more ...
Learn more about whether Globus Medical, Inc. or Lantheus Holdings, Inc. is a better investment based on AAII's A+ Investor ...
Remedy Pharmaceuticals, a leader in stroke drug development, today announced that the U.S. Patent and Trademark Office (USPTO) has allowed two additional patents covering its large hemispheric ...
4h
News-Medical.Net on MSN$1 million CPRIT grant focuses on AI to improve prostate cancer outcomesErzsébet Merényi, a statistics research professor at Rice University, and co-investigators at The University of Texas MD Anderson Cancer Center Pratip Bhattacharya, professor of cancer systems imaging ...
20h
inews.co.uk on MSNThe 20 most common conditions people claim PIP forPersonal independence payment claims for anxiety and depression have more than doubled since 2019, official statistics show ...
7h
Mamamia on MSNAustralian women do not feel well. When we asked them their symptoms, here’s what they said.Australian women are still suffering in silence.It's a confronting reality: 82 per cent of women feel they are the only ...
Myrobalan's experimental therapy MRO-002 is a GPR17 antagonist that's made to promote myelin repair in people with MS and other conditions.
Texas Tech has confirmed a potential measles exposure occurred over a multi-day period earlier this month in one its campus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results